239 related articles for article (PubMed ID: 15351215)
1. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
Hanna Z; Priceputu E; Kay DG; Poudrier J; Chrobak P; Jolicoeur P
Virology; 2004 Oct; 327(2):273-86. PubMed ID: 15351215
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
[TBL] [Abstract][Full Text] [Related]
3. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
[TBL] [Abstract][Full Text] [Related]
4. Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice.
Vincent P; Priceputu E; Kay D; Saksela K; Jolicoeur P; Hanna Z
J Biol Chem; 2006 Mar; 281(11):6940-54. PubMed ID: 16407193
[TBL] [Abstract][Full Text] [Related]
5. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
6. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Nef disrupts maturation of CD4+ T cells through CD4/Lck modulation.
Chrobak P; Simard MC; Bouchard N; Ndolo TM; Guertin J; Hanna Z; Dave V; Jolicoeur P
J Immunol; 2010 Oct; 185(7):3948-59. PubMed ID: 20826747
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation.
Aiken C; Krause L; Chen YL; Trono D
Virology; 1996 Mar; 217(1):293-300. PubMed ID: 8599214
[TBL] [Abstract][Full Text] [Related]
9. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
10. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells.
Ahmed Rahim MM; Chrobak P; Priceputu E; Hanna Z; Jolicoeur P
Virology; 2013 Apr; 438(2):84-97. PubMed ID: 23433958
[TBL] [Abstract][Full Text] [Related]
11. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration.
Brady HJ; Pennington DJ; Miles CG; Dzierzak EA
EMBO J; 1993 Dec; 12(13):4923-32. PubMed ID: 8262036
[TBL] [Abstract][Full Text] [Related]
12. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
13. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
Carl S; Greenough TC; Krumbiegel M; Greenberg M; Skowronski J; Sullivan JL; Kirchhoff F
J Virol; 2001 Apr; 75(8):3657-65. PubMed ID: 11264355
[TBL] [Abstract][Full Text] [Related]
14. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
Giese SI; Woerz I; Homann S; Tibroni N; Geyer M; Fackler OT
Virology; 2006 Nov; 355(2):175-91. PubMed ID: 16916529
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement.
Rhee SS; Marsh JW
J Immunol; 1994 May; 152(10):5128-34. PubMed ID: 8176229
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.
Weng X; Priceputu E; Chrobak P; Poudrier J; Kay DG; Hanna Z; Mak TW; Jolicoeur P
J Virol; 2004 May; 78(10):5244-57. PubMed ID: 15113906
[TBL] [Abstract][Full Text] [Related]
17. Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation.
Peng B; Robert-Guroff M
Immunol Lett; 2001 Oct; 78(3):195-200. PubMed ID: 11578695
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.
Wiskerchen M; Cheng-Mayer C
Virology; 1996 Oct; 224(1):292-301. PubMed ID: 8862424
[TBL] [Abstract][Full Text] [Related]
19. Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein.
Geyer M; Munte CE; Schorr J; Kellner R; Kalbitzer HR
J Mol Biol; 1999 May; 289(1):123-38. PubMed ID: 10339411
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.
Craig HM; Pandori MW; Riggs NL; Richman DD; Guatelli JC
Virology; 1999 Sep; 262(1):55-63. PubMed ID: 10489340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
